Cognitive impairment in amyotrophic lateral sclerosis
Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitiv...
Gespeichert in:
Veröffentlicht in: | Lancet neurology 2007-11, Vol.6 (11), p.994-1003 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1003 |
---|---|
container_issue | 11 |
container_start_page | 994 |
container_title | Lancet neurology |
container_volume | 6 |
creator | Phukan, Julie, MB Pender, Niall P, PhD Hardiman, Orla, MD |
description | Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration. |
doi_str_mv | 10.1016/S1474-4422(07)70265-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68409972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147444220770265X</els_id><sourcerecordid>1668635961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotlYfQRlciC5GkzSXmY0ixRsUXKjQXcikp5o6l5rMFPr2ZjqlQjdmkwvf-XLOj9ApwdcEE3HzRphkMWOUXmJ5JTEVPJ7sof7mWfD97ZnSHjryfo4xJSwhh6hHZMo44cM-4qPqs7S1XUJki4W2roCyjmwZ6WJV1a5afFkT5boGp_PImxxc5a0_RgcznXs42ewD9PH48D56jsevTy-j-3FsWCrrOBM4IYwZDZnklM9khqmWRgoBNA0r0zrFJqHZlLcXkeFEgKBcay15IvVwgC4678JVPw34WhXWG8hzXULVeCUShtNU0gCe74DzqnFl6E1RHFqQjA8DxDvIhCG8g5laOFtot1IEqzZUtQ5VtYkpLNU6VDUJdWcbeZMVMP2r2qQYgLsOgJDF0oJT3lgoDUytA1OraWX__eJ2x2ByW1qj829Ygd8OQ5QPdZ2kdWC5NkyGv5aXmuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201447453</pqid></control><display><type>article</type><title>Cognitive impairment in amyotrophic lateral sclerosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Phukan, Julie, MB ; Pender, Niall P, PhD ; Hardiman, Orla, MD</creator><creatorcontrib>Phukan, Julie, MB ; Pender, Niall P, PhD ; Hardiman, Orla, MD</creatorcontrib><description>Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(07)70265-X</identifier><identifier>PMID: 17945153</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alzheimer's disease ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - psychology ; Brain damage ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Cognition Disorders - etiology ; Cognition Disorders - psychology ; Cognitive ability ; Dementia ; Dementia - etiology ; Genes ; Growth factors ; Humans ; Incidence ; Motor neurone disease ; Mutation ; Neurodegeneration ; Neurology ; Neuropathology ; Neuropsychological Tests ; Pathology ; Prevalence</subject><ispartof>Lancet neurology, 2007-11, Vol.6 (11), p.994-1003</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Nov 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</citedby><cites>FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/201447453?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993,64383,64385,64387,72239</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17945153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phukan, Julie, MB</creatorcontrib><creatorcontrib>Pender, Niall P, PhD</creatorcontrib><creatorcontrib>Hardiman, Orla, MD</creatorcontrib><title>Cognitive impairment in amyotrophic lateral sclerosis</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.</description><subject>Alzheimer's disease</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - psychology</subject><subject>Brain damage</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - psychology</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Dementia - etiology</subject><subject>Genes</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Incidence</subject><subject>Motor neurone disease</subject><subject>Mutation</subject><subject>Neurodegeneration</subject><subject>Neurology</subject><subject>Neuropathology</subject><subject>Neuropsychological Tests</subject><subject>Pathology</subject><subject>Prevalence</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkMtKAzEUhoMotlYfQRlciC5GkzSXmY0ixRsUXKjQXcikp5o6l5rMFPr2ZjqlQjdmkwvf-XLOj9ApwdcEE3HzRphkMWOUXmJ5JTEVPJ7sof7mWfD97ZnSHjryfo4xJSwhh6hHZMo44cM-4qPqs7S1XUJki4W2roCyjmwZ6WJV1a5afFkT5boGp_PImxxc5a0_RgcznXs42ewD9PH48D56jsevTy-j-3FsWCrrOBM4IYwZDZnklM9khqmWRgoBNA0r0zrFJqHZlLcXkeFEgKBcay15IvVwgC4678JVPw34WhXWG8hzXULVeCUShtNU0gCe74DzqnFl6E1RHFqQjA8DxDvIhCG8g5laOFtot1IEqzZUtQ5VtYkpLNU6VDUJdWcbeZMVMP2r2qQYgLsOgJDF0oJT3lgoDUytA1OraWX__eJ2x2ByW1qj829Ygd8OQ5QPdZ2kdWC5NkyGv5aXmuA</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Phukan, Julie, MB</creator><creator>Pender, Niall P, PhD</creator><creator>Hardiman, Orla, MD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Cognitive impairment in amyotrophic lateral sclerosis</title><author>Phukan, Julie, MB ; Pender, Niall P, PhD ; Hardiman, Orla, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Alzheimer's disease</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - psychology</topic><topic>Brain damage</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - psychology</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Dementia - etiology</topic><topic>Genes</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Incidence</topic><topic>Motor neurone disease</topic><topic>Mutation</topic><topic>Neurodegeneration</topic><topic>Neurology</topic><topic>Neuropathology</topic><topic>Neuropsychological Tests</topic><topic>Pathology</topic><topic>Prevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phukan, Julie, MB</creatorcontrib><creatorcontrib>Pender, Niall P, PhD</creatorcontrib><creatorcontrib>Hardiman, Orla, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phukan, Julie, MB</au><au>Pender, Niall P, PhD</au><au>Hardiman, Orla, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive impairment in amyotrophic lateral sclerosis</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>6</volume><issue>11</issue><spage>994</spage><epage>1003</epage><pages>994-1003</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17945153</pmid><doi>10.1016/S1474-4422(07)70265-X</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1474-4422 |
ispartof | Lancet neurology, 2007-11, Vol.6 (11), p.994-1003 |
issn | 1474-4422 1474-4465 |
language | eng |
recordid | cdi_proquest_miscellaneous_68409972 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
subjects | Alzheimer's disease Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - psychology Brain damage Cognition Disorders - diagnosis Cognition Disorders - epidemiology Cognition Disorders - etiology Cognition Disorders - psychology Cognitive ability Dementia Dementia - etiology Genes Growth factors Humans Incidence Motor neurone disease Mutation Neurodegeneration Neurology Neuropathology Neuropsychological Tests Pathology Prevalence |
title | Cognitive impairment in amyotrophic lateral sclerosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A46%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20impairment%20in%20amyotrophic%20lateral%20sclerosis&rft.jtitle=Lancet%20neurology&rft.au=Phukan,%20Julie,%20MB&rft.date=2007-11-01&rft.volume=6&rft.issue=11&rft.spage=994&rft.epage=1003&rft.pages=994-1003&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(07)70265-X&rft_dat=%3Cproquest_cross%3E1668635961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201447453&rft_id=info:pmid/17945153&rft_els_id=1_s2_0_S147444220770265X&rfr_iscdi=true |